- Platform Stem Cell Technology
Tissue Repair Cell (TRC) technology
- Over 375 Patients Treated to Date
- Active Clinical Trial Program
- Comprehensive Patent Portfolio
U.S. Patents – 26 issued, 4 pending
Foreign Patents – 41 issued, 4 pending
- Headquarters – Ann Arbor, Michigan
|
